NCT07045259 Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome
| NCT ID | NCT07045259 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Motoric Cognitive Risk Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-12-25 |
| Primary Completion | 2026-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-12-25 with a primary completion date of 2026-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and dementia and mild cognitive impairment. This study aims to present for the first time the effects of neuromuscular exercise training and exergaming program on locomotor and cognitive functions in elderly individuals with MCR with comparative results.
Eligibility Criteria
Inclusion Criteria: * Being over 65 years of age * Having a Barthel Daily Living Activities Index score of ≥ 90 * Having a Mini Mental Status Score (MMSE) of ≥24 * Having the ability to walk with or without a walking aid * Having a slow walking speed * Having subjective memory complaints Exclusion Criteria: * Presence of Dementia * Major Depression * Generalized Anxiety Disorder and Delirium * Parkinson's Disease * Anemia * Thyroid Disease * Vitamin B12 Deficiency * Malnutrition * Terminal Illness * Hearing or Visual Impairment
Contact & Investigator
Gulfidan TOKGÖZ, Lecturer, PhD (c)
PRINCIPAL INVESTIGATOR
İstanbul University-Cerrahpasa
Frequently Asked Questions
Who can join the NCT07045259 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Motoric Cognitive Risk Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07045259 currently recruiting?
Yes, NCT07045259 is actively recruiting participants. Contact the research team at gulfidan.tokgoz@gmail.com for enrollment information.
Where is the NCT07045259 trial being conducted?
This trial is being conducted at Balıkesir, Turkey (Türkiye).
Who is sponsoring the NCT07045259 clinical trial?
NCT07045259 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Gulfidan TOKGÖZ, Lecturer, PhD (c) at İstanbul University-Cerrahpasa. The trial plans to enroll 60 participants.